| http://www.w3.org/ns/prov#value | - Bristol-Myers Squibb is a global biopharmaceutical leader with expertise developing and commercializing novel medicines for the treatment of cancer and other diseases, and we are pleased to enter into a third collaboration with the company to include another aspect of our technology platform, said Lawson Macartney, Ph.D., chief executive officer of Ambrx.
|
